Scientific Session
Immunobiology
J. Michelle Kahlenberg, MD,PhD
University of Michigan
Ann Arbor, MI, United States
Disclosure(s): AnaptysBio: Advisor or Review Panel Member (Terminated, May 1, 2024); Biogen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Terminated, November 30, 2024), Grant/Research Support (Terminated, November 30, 2024); EMD Serano: Advisor or Review Panel Member (Ongoing); Exo Therapeutics: Consultant (Terminated, July 1, 2024); Gilead: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Related Science LLC: Consultant (Ongoing); Rome Therapeutics: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Seismic Therapeutics: Advisor or Review Panel Member (Ongoing); Synthekine: Advisor or Review Panel Member (Terminated); Ventus Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Vividion: Advisor or Review Panel Member (Ongoing)